SentiSense
Ctrl+K
Quick tip: Press
to search stocks
D
DXCM
DexCom, Inc.
$68.10
-2.59 (-3.66%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$68.10
Live market price
P/E (TTM)
32.58
EPS: $2.09
P/S (TTM)
5.62
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 10:24:38 PM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
14.6M
% of Float
3.8%
Days to Cover
2.4
Avg Daily Vol
6.0M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.53
Leverage ratio
ROE (TTM)
30.46%
Return on equity
Income Statement
Revenue
$4.66B
Cost of Revenue
$1.86B
Gross Profit
$2.80B
Operating Income
$911.80M
Net Income
$836.30M
EPS (Quarter)
$2.09
EPS (TTM)
--
Balance Sheet
Total Assets
$6.34B
Total Liabilities
$3.59B
Shareholders' Equity
$2.75B
Current Assets
$4.03B
Current Liabilities
$2.14B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$1.44B
Investing Cash Flow
$536.00M
Financing Cash Flow
$-1.69B
Free Cash Flow
$1.98B
Profitability Margins
Gross Margin
60.10%
Operating Margin
19.56%
Net Profit Margin
17.94%
ROA (TTM)
13.19%
ROE (TTM)
30.46%
Data source: Polygon.io
Last updated: 3/8/2026, 10:24:39 PM
Company Profile
Symbol
DXCM
Market Cap
$26.21B
IPO Date
Apr 14, 2005
CEO
--
Employees
11,100
Sector
--
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Country
United States
Exchange
--
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Read More